quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:19:00·21d
PRRelease
PureTech Health plc logo

PureTech Announces Publication of Phase 2b ELEVATE IPF Trial Results in The American Journal of Respiratory and Critical Care Medicine

PRTC· PureTech Health plc
Health Care
Original source

Companies

  • PRTC
    PureTech Health plc
    Health Care

Recent analyst ratings

  • Sep 9UpdateLeerink Partners$45.00
  • Jan 7UpdateSVB Leerink$70.00
  • Aug 25UpdateSVB Leerink$76.00

Related

  • PR11d
    PureTech Health: Notice of Results
  • PR22d
    PureTech Founded Entity Seaport Therapeutics Announces Positive Proof of Concept Topline Results from Ongoing Phase 1 Trial of GlyphAgo™ in Healthy Volunteers
  • PR29d
    PureTech Founded Entity Seaport Therapeutics Announces Publication in Science Translational Medicine Featuring GlyphAllo™ (SPT-300) as the First Triglyceride-Mimetic Prodrug to Achieve Therapeutically Relevant Drug Levels in Humans
  • PR58d
    PureTech to Present at the Leerink Partners Global Healthcare Conference
  • PR63d
    PureTech Announces Orphan Drug Designations Granted by the U.S. Food and Drug Administration and European Commission for Deupirfenidone (LYT-100) in Idiopathic Pulmonary Fibrosis
  • PR107d
    PureTech to Present at 44th Annual J.P. Morgan Healthcare Conference
  • SEC126d
    SEC Form 6-K filed by PureTech Health plc
  • PR127d
    PureTech Appoints Robert Lyne as Chief Executive Officer
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022